⌘K

Login Start Free

Home/Filings/4/0001062993-25-004077

4//SEC Filing

BUCHI J KEVIN 4

Accession 0001062993-25-004077

CIK 0001808898other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 2:20 PM ET

Size

6.3 KB

Accession

0001062993-25-004077

Insider Transaction Report

Form 4

Period: 2025-02-27

Benitec Biopharma Inc.BNTC

Director

Transactions

Exercise/Conversion
Common Warrants (right to buy)
2025-02-27−51,813→ 0 total
Exercise: $3.86From: 2023-08-11Exp: 2028-08-11→ Common Stock (51,813 underlying)
Exercise/Conversion
Common Stock
2025-02-27$3.86/sh+51,813$199,998→ 103,910 total

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother

Related Parties

1

filerCIK 0001209726

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 2:20 PM ET
Size: 6.3 KB

View on SEC.gov